Table 1 Definition criteria for the diagnosis of MetS according to the different organizations

Glucose metabolism (FG MG/DL)

IGT, IFG, T2DM or lowered insulin sensitivity^†

IR^‡

FG ≥ 110

IGT or IFG (but not diabetes)^†

FG ≥ 100

FG ≥ 100 or

T2DM

FG ≥ 100 or treatment

Obesity (BMI KG/M², WC CM)

WHR(m) > 0.90 WHR(f) ˃ 0.85 or BMI ˃ 30

WC(m) ≥ 94 WC(f) ≥ 80

BMI ˃ 25

WC(m) ≥ 102 WC(f) ≥ 88

Elevated WC, ethnicity, and gender specific^†

Elevated WC, population, and country specific

Dyslipidemia (TG, HDL-C MG/DL)

TG ˃ 150 or HDL-C(m) ˂ 35 HDL-C(f) ˂ 39

TG ˃ 177 or HDL-C ˂ 39

TG ≥ 150 or HDL-C(m) ˂ 40, HDL-C(f) ˂ 50

TG ≥ 150 or HDL-C(m) ˂ 40, HDL-C(f) ˂ 50

TG ≥ 150 or treatment or HDL-C(m) ˂ 40, HDL-C(f) ˂ 50 or treatment

TG ≥ 150 or treatment or HDL-C(m) ˂ 40, HDL-C(f) ˂ 50 or treatment

Hypertension (BP MMHG)

 ≥ 140/90

 ≥ 140/90

 ≥ 130/85

 ≥ 130/85

 ≥ 130/85 or treatment

 ≥ 130/85 or treatment

Other factors

Microalbominuria ˃ 30 mg/g

Not relevant

Other risk factors^§

Not relevant

Not relevant

Not relevant